Global Pain Relief Therapeutics Market 2018-20214
26-May-2018 | Number of pages: 212 | Report Id: BMRC PH 122 | Report Format: | Status: Upcoming

Overview of the Pain Relief Therapeutics Market: Future Insights, Market Revenue and Threat Forecast by 2024

Brandessence Market Research is working on a new report titleGlobal Pain Relief Therapeutics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″.The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics Market.

Global Pain Relief Therapeutics Market Reports –

An unpleasant sensation that can range from mild to localized discomfort and which occurs due to tissue damage or illness.The duration of pain differs from short term known as acute pain to long term known as chronic pain.Pain that occurs quickly, but lasts for shorter duration of time such as 3 to 6 months is called Acute Pain.Pain that lasts for more than 12 weeks and isarising from an initial injury, such as a back sprain is called as Chronic Pain.

The symptomsof Pain are weakness, fever, muscle cramps,Abdominal pain, Blood in stool,Cough, Diarrhea, Difficulty swallowing and Dizziness.There is no such test that can measure and locate pain with precision. So, doctors relay on the patient’s own description of the type, timing, and location of pain. Description of painsuch as sharp or dull, constant or on-and-off, or burning or aching might give the best clues to the cause of the pain. These descriptions are called as the pain history, taken during the start of the evaluation of a patient with pain.

Moreover chronic pain can occurs in a various parts of body and for different reasons so patients and their doctorsmust work together to recognize the causes and symptoms of that pain and how it can be treated in early stage.

Although technology can help doctorsfor diagnosis, the best treatment plans are personalized to the person, with efforts from healthcare team, who all have different training backgrounds and understand chronic pain. The person suffering from pain and his or her loved ones also must be actively involved in the treatment. Drugs used to treat Pain are Acetaminophen, Codeine, Ibuprofen, Morphine and many mores.

Global Pain Relief Therapeutics Market is segmented on the basis of Therapeutics, Indication, Distribution channeland Geography. On the Basis of Therapeutics, Global Pain Relief Therapeutics Market is classified as Non-steroidal Anti-inflammatory Drugs (NSAID’s), Anesthetics, Anticonvulsant, Antimigrane Agents, Antidepressants, Opioids, Nonnarcotic Analgesics and Others. On the basis of IndicationGlobal Pain Relief Therapeutics Market is classified into Arthritic Pain, Cancer Pain, Neuropathic Pain, Chronic back Pain, Post-operative Pain, Migraine, Fibromyalgia andothers. On the basis of Distribution channelGlobal Pain Relief Therapeutics Market is classified asHospital Pharmacy, Drug Stores, Online Pharmacy and Other.

The regions covered in Global Pain Relief Therapeutics Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Pain Relief Therapeutics Market Reports –

Global Pain Relief Therapeutics Market reports cover prominent players likeNovartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., BoehringerIngelheim, Sorrento Therapeutics, WEX Pharmaceuticals, Mallinckrodt plc, Teva Pharmaceuticals   and Zynerba Pharmaceuticals, AstraZeneca Inc., Depomed Inc., MaynePharma Group Limited, Sanofi Inc., Beiersdorf AG, Astellas Pharmaceuticals Inc., Durect Corporation, AcelRx Pharmaceuticals, Inc., Acorda Therapeutics Inc., Achelios Therapeutics, Amgen Inc., Cara Therapeutics, Avanir Pharmaceuticals Inc., Axsome Therapeutics Inc.,  BioDelivery Sciences International, COLLEGIUM Pharmaceutical Inc., Centrexion Therapeutics, Daiichi Sankyo Company Ltd., Egalet Corporation, EpiCept, FemmePharma, Flexion Therapeutics Inc., Galapagos NV, Heron Therapeutics, Helsinn Healthcare, Sainsys Therapeutics Inc, Iroko Pharmaceuticals, KemPharm Inc., Mesoblast Ltd, Nektar Therapeutics, NeurAxon, Newron Pharmaceuticals, Olatec Industries, Otsuka Pharmaceutical, PLxPharma, Orexo AB, Regeneron Pharmaceuticals Inc., RecroPharmaInc, Relmada TherapeuticsInc, Scintilla Pharmaceuticals Inc.and others.

Global Pain Relief Therapeutics Market Dynamics –

Rising geriatric population and increasing incidence of chronic diseases such as nerve damage, depression, epilepsy, bone or joint pain, and injuries etc., are key factors driving growth of Global Pain Relief Therapeutics Market. Changing lifestyle, early onset of aging, and increasing awareness about of pain management therapeutics are other growth drivers of the Global Pain Relief Therapeutics Market.

However, side-effects such as allergic reactions including rash, itching and swellingof face, throat and tongue caused by certain Pain Relief Therapeutics is a key factor restraining growth of the Global Pain Relief Therapeutics Market. Additionally, availability of other generic pain relief therapeutics, increasing preference for this genericpain relief therapeuticsby the general population and Drug Abuse are major factors that expected to hinder growth of the Global Pain Relief Therapeutics Market over the forecast period.

Additionally, favorable regulations are playing a key role in the increased rate of development, approval, and commercialization of novel molecule combinations and drug delivery techniques in the Global Pain Relief Therapeutics Market sector. The advancements in drug development and the investigation of a large number of regulatory healthcare reforms, favoring development of methods for the improved diagnosis and treatment of chronic pain, will help the Global Pain Relief Therapeutics Market tread along a promising growth path in the next few years.

 Global Pain Relief Therapeutics Market Regional Analysis –

 North America held the leading share in the Global Pain Relief Therapeutics Market. The growth of this regional market is mainly because of favorable reimbursement policies for prescription drugs used for Pain Relief Therapeutics and availability of a spectrum of over-the-counter drugs for PainRelief Therapeutics.The existence of better drug manufacturers is expected to have positive impact on the North America market for Pain Relief Therapeutics in the future.Asia Pacific is expected to observe the leading growth rate due to a growing geriatric population, rising awareness to health problems in a timely manner and increased focus of leading companies to tap into growth opportunities in China and India.Furthermore, increase in awareness through various government and NGO campaigns of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.

Key Benefits for Global Pain Relief Therapeutics Market Reports –

  • Global Pain Relief Therapeutics Market report covers in depth historical and forecast analysis.
  • Global Pain Relief Therapeutics Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Pain Relief Therapeutics Market report helps to identify opportunities in market place.
  • Global Pain Relief Therapeutics Market report covers extensive analysis of emerging trends and competitive landscape.

Global Pain Relief Therapeutics Market Segmentation

Global Pain Relief Therapeutics Market: By Therapeutics Analysis

  • Non-steroidal Anti-inflammatory Drugs (NSAID’s)
  • Anesthetics
  • Anticonvulsant
  • Antimigrane Agents
  • Antidepressants
  • Opioids
  • Nonnarcotic Analgesics
  • Others

Global Pain Relief Therapeutics Market: By Indication Analysis

  • Arthritic Pain
  • Cancer Pain
  • Neuropathic Pain
  • Chronic back Pain
  • Post-operative Pain
  • Migraine
  • Fibromyalgia
  • Others

Global Pain Relief Therapeutics Market: By Distribution channel Analysis

  • Hospital Pharmacy
  • Drug Stores
  • Online Pharmacy
  • Others

Global Pain Relief Therapeutics Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Pain Relief Therapeutics Market 2018-2024

Our 212 pages report provides 78 tables, 71 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Pain Relief Therapeutics Market
  • To receive forecasts of Global Pain Relief Therapeutics Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Global Pain Relief Therapeutics Market sector
  • To determine the forces and factor that influences the market for Global Pain Relief Therapeutics Market: drivers, restraints, opportunities and threats
  • To find out where the Global Psoriasis Drug Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Pain Relief Therapeutics Market: By Region Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Pain Relief Therapeutics Market: By Therapeutics Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Non-Steroidal Anti-inflammatory Drugs(NSAID’s) XX XX XX XX XX
Anaesthetics XX XX XX XX XX
Anticonvulsant XX XX XX XX XX
Antimigraine Agents XX XX XX XX XX
Antidepressants XX XX XX XX XX
Opioids XX XX XX XX XX
Non-narcotic Analgesics XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Pain Relief Therapeutics Market: By Indication Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Arthritic Pain XX XX XX XX XX
Cancer Pain XX XX XX XX XX
Neuropathic Pain XX XX XX XX XX
Chronic back Pain XX XX XX XX XX
Post-operative Pain XX XX XX XX XX
Migraine XX XX XX XX XX
Fibromyalgia XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Pain Relief Therapeutics Market: By Distribution Channel Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Hospital Pharmacy XX XX XX XX XX
Drug Stores XX XX XX XX XX
Online Pharmacy XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

  • This report features news, insights, the latest developments and an in depth survey ofGlobal Pain Relief Therapeutics Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • Novartis AG
  • Eli Lilly & Company
  • Abbott Laboratories
  • Endo Health Solutions Inc.
  • Purdue Pharma L.P.
  • Pfizer Inc.
  • F. Hoffmann La Roche Ltd.
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline Plc.
  • Allergen Inc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Valeant Pharmaceuticals International Inc.
  • Boehringer Ingelheim
  • Sorrento Therapeutics
  • WEX Pharmaceuticals
  • Mallinckrodt plc
  • Teva Pharmaceuticals
  • Zynerba Pharmaceuticals
  • AstraZeneca Inc.
  • Depomed Inc.
  • Mayne Pharma Group Limited
  • Sanofi Inc.
  • Beiersdorf AG
  • Astellas Pharmaceuticals Inc.
  • Durect Corporation
  • AcelRx Pharmaceuticals Inc.
  • Acorda Therapeutics Inc.
  • Achelios Therapeutics
  • Amgen Inc.
  • Cara Therapeutics
  • Avanir Pharmaceuticals Inc.
  • Axsome Therapeutics Inc.
  • BioDelivery Sciences International
  • COLLEGIUM Pharmaceutical Inc.
  • Centrexion Therapeutics
  • Daiichi Sankyo Company Ltd.
  • Egalet Corporation
  • EpiCept
  • FemmePharma
  • Flexion Therapeutics Inc.
  • Galapagos NV
  • Heron Therapeutics
  • Helsinn Healthcare
  • Sainsys Therapeutics Inc
  • Iroko Pharmaceuticals
  • KemPharm Inc
  • Mesoblast Ltd
  • Nektar Therapeutics
  • NeurAxon
  • Newron Pharmaceuticals
  • Olatec Industries
  • Otsuka Pharmaceutical
  • PLx Pharma
  • Orexo AB
  • Regeneron Pharmaceuticals Inc
  • Recro Pharma Inc.
  • Relmada Therapeutics Inc.
  • Scintilla Pharmaceuticals
  • Others

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Pain Relief Therapeutics Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Pain Relief Therapeutics Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Pain Relief Therapeutics Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Pain Relief Therapeutics Market Overview: Quantitative Analysis
    • 2. Global Pain Relief Therapeutics  Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Pain Relief Therapeutics Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Pain Relief Therapeutics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter – Global Pain Relief Therapeutics Market: by Therapeutics
  3. Chapter – Global Pain Relief Therapeutics Market: by Indication
  4. Chapter – Global Pain Relief Therapeutics Market: by Distribution Channel
    • Global Pain Relief Therapeutics Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Pain Relief Therapeutics MarketProduction (K Unit), by Manufacturer, 2014 – 2024
    • Global Pain Relief Therapeutics Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Pain Relief Therapeutics Market Share (%), by Manufacturer, 2017
    • Global Pain Relief Therapeutics Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Pain Relief Therapeutics Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  5. Chapter – Global Pain Relief Therapeutics Market: Regional Analysis
    • North America
    • North America Global Pain Relief Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Pain Relief Therapeutics Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Pain Relief Therapeutics Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Pain Relief Therapeutics MarketRevenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Pain Relief Therapeutics MarketRevenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Pain Relief Therapeutics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  6. Chapter – Company Profiles
    • Novartis AG
    • Overview
    • Financials
    • Product portfolio
  • Global Pain Relief Therapeutics Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
  • Global Pain Relief Therapeutics Market Share (%), 2014 – 2017
    • Business strategy
    • Recent developments
  • Eli Lilly & Company
  • Abbott Laboratories
  • Endo Health Solutions Inc.
  • Purdue Pharma L.P.
  • Pfizer Inc.
  • Hoffmann La Roche Ltd.
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline Plc.
  • Allergen Inc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Valeant Pharmaceuticals International Inc.
  • Boehringer Ingelheim
  • Sorrento Therapeutics
  • WEX Pharmaceuticals
  • Mallinckrodt plc
  • Teva Pharmaceuticals
  • Zynerba Pharmaceuticals
  • AstraZeneca Inc.
  • Depomed Inc.
  • Mayne Pharma Group Limited
  • Sanofi Inc.
  • Beiersdorf AG
  • Astellas Pharmaceuticals Inc.
  • Durect Corporation
  • AcelRx Pharmaceuticals Inc.
  • Acorda Therapeutics Inc.
  • Achelios Therapeutics
  • Amgen Inc.
  • Cara Therapeutics
  • Avanir Pharmaceuticals Inc.
  • Axsome Therapeutics Inc.
  • BioDelivery Sciences International
  • COLLEGIUM Pharmaceutical Inc.
  • Centrexion Therapeutics
  • Daiichi Sankyo Company Ltd.
  • Egalet Corporation
  • EpiCept
  • FemmePharma
  • Flexion Therapeutics Inc.
  • Galapagos NV
  • Heron Therapeutics
  • Helsinn Healthcare
  • Sainsys Therapeutics Inc.
  • Iroko Pharmaceuticals
  • KemPharm Inc.
  • Mesoblast Ltd
  • Nektar Therapeutics
  • NeurAxon
  • Newron Pharmaceuticals
  • Olatec Industries
  • Otsuka Pharmaceutical
  • PLx Pharma
  • Orexo AB
  • Regeneron Pharmaceuticals Inc.
  • Recro Pharma Inc.
  • Relmada Therapeutics Inc.
  • Scintilla Pharmaceuticals
  • Others
  1. Chapter – Market Research and Findings

  • Novartis AG
  • Eli Lilly & Company
  • Abbott Laboratories
  • Endo Health Solutions Inc.
  • Purdue Pharma L.P.
  • Pfizer Inc.
  • F. Hoffmann La Roche Ltd.
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline Plc.
  • Allergen Inc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Valeant Pharmaceuticals International Inc.
  • Boehringer Ingelheim
  • Sorrento Therapeutics
  • WEX Pharmaceuticals
  • Mallinckrodt plc
  • Teva Pharmaceuticals
  • Zynerba Pharmaceuticals
  • AstraZeneca Inc.
  • Depomed Inc.
  • Mayne Pharma Group Limited
  • Sanofi Inc.
  • Beiersdorf AG
  • Astellas Pharmaceuticals Inc.
  • Durect Corporation
  • AcelRx Pharmaceuticals Inc.
  • Acorda Therapeutics Inc.
  • Achelios Therapeutics
  • Amgen Inc.
  • Cara Therapeutics
  • Avanir Pharmaceuticals Inc.
  • Axsome Therapeutics Inc.
  • BioDelivery Sciences International
  • COLLEGIUM Pharmaceutical Inc.
  • Centrexion Therapeutics
  • Daiichi Sankyo Company Ltd.
  • Egalet Corporation
  • EpiCept
  • FemmePharma
  • Flexion Therapeutics Inc.
  • Galapagos NV
  • Heron Therapeutics
  • Helsinn Healthcare
  • Sainsys Therapeutics Inc
  • Iroko Pharmaceuticals
  • KemPharm Inc
  • Mesoblast Ltd
  • Nektar Therapeutics
  • NeurAxon
  • Newron Pharmaceuticals
  • Olatec Industries
  • Otsuka Pharmaceutical
  • PLx Pharma
  • Orexo AB
  • Regeneron Pharmaceuticals Inc
  • Recro Pharma Inc.
  • Relmada Therapeutics Inc.
  • Scintilla Pharmaceuticals
  • Others